VR

Venkatakrishna Reddy Vempalli

Active Director Director DIN 00024216
DIN 00024216 First appointment Jul 1995 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Jul 1995
Shareholding value •••• Premium profile

About Venkatakrishna Reddy Vempalli

Data last updated:

Venkatakrishna Reddy Vempalli has 31 years in corporate governance. Holds Director and Managing Director roles. Currently with 3 companies, including Sri Krishna Drugs Limited and Sri Krishna Pharmaceuticals Limited. Formerly with 5 companies, such as Kellton Securities Private Limited and Kellton Commodity And Derivatives Private Limited. Engaged in General Business, Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹608 Cr; the largest is Sri Krishna Pharmaceuticals Limited at ₹608 Cr (FY 2025).

DIN 00024216
Primary Designation Director
First Appointment 26 Jul 1995
Oldest Company Age 52 yrs
Largest company Sri Krishna Pharmaceuticals Limited · ₹608 Cr (FY 2025)
Combined revenue ₹608 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sri Krishna Pharmaceuticals Limited U24230TG1974PLC001790
Managing Director15 Oct 19971974₹608 Cr (FY 2025)Active
Clonz Biotech Private Limited U24231TG2009PTC065376
Director09 Sep 20202009₹24.4 Lakh (FY 2025)Active
Sri Krishna Biofert Private Limited U24120TG1995PTC021782
Director21 Sep 19951995₹1.1 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kellton Securities Private Limited U65910TG1990PTC011408
Director11 Oct 19971990₹1.55 Cr (FY 2025)Active
Director26 Jul 19951995–Active
Sri Krishna Drugs Limited L24110TG1985PLC005315
Director04 Jun 19981985–Amalgamated
Sripad Equities Private Limited U67120TG1995PTC021206
Director26 Jul 19951995₹2.6 Lakh (FY 2016)Dissolved (Liquidated)
Ensolvia Infotech Limited U72200TG2000PLC034518
Director29 May 20002000₹86,287 (FY 2019)Dissolved (Liquidated)

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sri Krishna Drugs Limited
Sri Krishna Pharmaceuticals Limited
Sri Krishna Biofert Private Limited
Clonz Biotech Private Limited
Premium access

Shareholding and investment profile for Venkatakrishna Reddy Vempalli

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkatakrishna Reddy Vempalli

Venkatakrishna Reddy Vempalli has 31 years in corporate governance. Holds Director and Managing Director roles. Currently with 3 companies, including Sri Krishna Drugs Limited and Sri Krishna Pharmaceuticals Limited. Formerly with 5 companies, such as Kellton Securities Private Limited and Kellton Commodity And Derivatives Private Limited. Engaged in General Business, Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹608 Cr; the largest is Sri Krishna Pharmaceuticals Limited at ₹608 Cr (FY 2025).

Venkatakrishna Reddy Vempalli is associated with 3 companies as Director and Managing Director, including Sri Krishna Pharmaceuticals Limited (₹608 Cr), Clonz Biotech Private Limited (₹24.4 Lakh), Sri Krishna Biofert Private Limited (₹1.1 Lakh).

Venkatakrishna Reddy Vempalli has expertise in General Business, Technology.

Venkatakrishna Reddy Vempalli has 31 years in corporate governance.

By reported revenue, the largest current company of Venkatakrishna Reddy Vempalli is Sri Krishna Pharmaceuticals Limited, with revenue of ₹608 Cr (FY 2025).

The 3 current companies of Venkatakrishna Reddy Vempalli that report revenue have a combined latest revenue of ₹608 Cr.

Venkatakrishna Reddy Vempalli currently holds positions at 3 companies: Sri Krishna Pharmaceuticals Limited (₹608 Cr), Clonz Biotech Private Limited (₹24.4 Lakh), Sri Krishna Biofert Private Limited (₹1.1 Lakh).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available